PRAMEF20: A Protein with Potential as A Drug Target and Biomarker

Target Name: PRAMEF20

NCBI ID: G645425

PRAMEF20

PRAMEF20: A Protein with Potential as A Drug Target and Biomarker

PRAMEF20 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of the immune response and has been implicated in a number of diseases, including cardiovascular disease, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of PRAMEF20 is its role in the regulation of inflammation. It has been shown to play a key role in the regulation of inflammatory responses in the brain, and has been implicated in the development of neurodegenerative diseases.

In addition to its role in inflammation, PRAMEF20 is also involved in the regulation of cell growth and has been shown to play a key role in the regulation of cell division in various tissues.

As a drug target, PRAMEF20 is a promising target for the development of new treatments for a number of diseases. Its role in the regulation of inflammation and its involvement in the regulation of cell growth make it a potential target for a variety of therapeutic approaches, including anti-inflammatory drugs, anti-cancer drugs, and drugs that target the regulation of cell division.

In addition to its potential as a drug target, PRAMEF20 is also a potential biomarker for a number of diseases. Its expression has been shown to be elevated in a variety of diseases, including neurodegenerative diseases, and its levels have been used as a biomarker for monitoring the effectiveness of certain treatments.

Overall, PRAMEF20 is a protein that has the potential to be a drug target and a biomarker for a variety of diseases. Further research is needed to fully understand its role in the regulation of inflammation and its potential as a therapeutic approach.

Protein Name: PRAME Family Member 20

The "PRAMEF20 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRAMEF20 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets